Delivery Order SPE2DB20D1102-SPE2DB24FC6GA
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $1,122.70 and a period of performance through March 19, 2024. This delivery order is issued under an Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $95,105.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a total ceiling value of $3,215.14 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with expertise...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract has a potential value of $3,395.16 and a completion date of February 23, 2024. The contract is for the delivery of HAVRIX 720 unit/0.5 mL syringes. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $2,420.70 and runs through March 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,804.95 and a completion date of June 21, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. In addition to this specific...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $1,143.30. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,906,226 units of the HAVRIX 720 0.5 ML syringe vaccine. The contract has a ceiling value of $2,309.50 and a period of performance through March 11, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 1,440 unit/mL syringes, with a total ceiling value of $16,541.45 and a period of performance through June 9, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/mL syringes. The contract has a ceiling value of $2,286.60 and a period of performance through September 9, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to the U.S. government,...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB24FC6GADelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of HAVRIX 1,440 unit/mL syringes, a specialty pharmaceutical product. The total ceiling value of this delivery order is $3,811.00 with a period of performance through March 27, 2024. AmerisourceBergen Drug Corp has been awarded this delivery order under a larger indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 3/26/24 |